Unveiling Phenotypic Heterogeneity in Coronary Spastic Angina Through Multidimensional Risk Profiling

Read full text Summarise with VIRAT
Authors: Takamitsu Nakamura, Tuan Hoang Nguyen, Takeo Horikoshi, Juntaro Deyama, Manabu Uematsu, Toru Yoshizaki, Tsuyoshi Kobayashi, Kazuto Nakamura, Akira Sato
Cited by: 0
References: 32

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Coronary spastic angina (CSA) is a functional coronary disorder causing recurrent ischemia without significant atherosclerosis, but the interaction between metabolic and inflammatory abnormalities remains unclear. OBJECTIVES: The purpose of this study was to identify clinically meaningful CSA phenotypes based on metabolic and inflammatory profiles and to determine phenotype-specific determinants of coronary spasm and endothelial dysfunction. METHODS: We analyzed 568 patients with suspected CSA and no obstructive coronary artery disease from the FUJI-SPASM (Feature-based Understanding of Joint Investigation for coronary Spasm Phenotypes and Associated Stratified Mechanisms) registry. Coronary spasm was assessed using intracoronary acetylcholine provocation testing. Unsupervised k-means clustering was performed using 20 standardized clinical and biochemical variables. Phenotype-specific determinants of spasm were identified using adaptive least absolute shrinkage and selection operator regression followed by multivariable logistic regression within each cluster. Endothelial function was assessed by flow-mediated dilation in a subset of 159 patients. RESULTS: Two phenotypes were identified. Cluster 0 (n = 231) showed metabolically dominant profiles with atherogenic dyslipidemia and insulin resistance, whereas cluster 1 (n = 337) showed inflammation-dominant profiles with preserved lipid levels but elevated high-sensitivity C-reactive protein (hs-CRP). Lower high-density lipoprotein cholesterol (HDL-C) was associated with coronary spasm in both clusters, while higher hs-CRP was independently associated with spasm only in the inflammation-dominant cluster. An HDL-C/hs-CRP-based stratification demonstrated a graded increase in spasm prevalence and worsening endothelial function. CONCLUSIONS: CSA comprises distinct metabolic and inflammatory phenotypes with differing determinants of coronary spasm and endothelial dysfunction. Reduced HDL-C represents a shared vulnerability across phenotypes, while inflammation confers additional risk. HDL-C/hs-CRP-based stratification provides a clinically accessible framework for individualized CSA risk assessment.

Fields of Study & Subjects

Cardiac Imaging and Diagnostics Diabetes Cardiovascular Risks and Lipoproteins Nitric Oxide and Endothelin Effects

Publication details

Journal / source
JACC Advances
Volume
5
Issue
3
Pages
102628–102628
Publication date
1 March 2026
Language
EN